IVERIC bio (ISEE) Short Interest Ratio & Short Volume

Short interest is the volume of IVERIC bio shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 16,640,000 shares of ISEE short. Learn More on IVERIC bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ISEE shares currently have a short interest ratio of 4.0. Learn More on IVERIC bio's short interest ratio.

IVERIC bio saw a increase in short interest in June. As of June 15th, there was short interest totaling 16,640,000 shares, an increase of 10.4% from the previous total of 15,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to IVERIC bio: RayzeBio, Inc. (2.32%), Crinetics Pharmaceuticals, Inc. (7.05%), ImmunoGen, Inc. (7.74%), Roivant Sciences Ltd. (5.59%), Option Care Health, Inc. (2.67%), Blueprint Medicines Co. (7.14%), Revolution Medicines, Inc. (7.29%), Ionis Pharmaceuticals, Inc. (7.11%), Bausch + Lomb Co. (3.92%), CRISPR Therapeutics AG (17.39%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling ISEE is an investing strategy that aims to generate trading profit from IVERIC bio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for IVERIC bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ISEE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ISEE, twice per month. The most recent reporting period available is June, 15 2023.